| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0235591674342976 | 0.083491285 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0235591674342976 | 0.069347008 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0235591674342976 | -0.064202728 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0235591674342976 | -0.071808729 |
| NSC 737757 | 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole | 0.0235591674342976 | 0.086744409 |
| NSC 744063 | Null | 0.0235591674342976 | -0.014524022 |
| NSC 753907 | Null | 0.0280810439814505 | 0.24954058 |
| NSC 755264 | Null | 0.0280810439814505 | 0.13396157 |
| NSC 755267 | Null | 0.0280810439814505 | 0.11225796 |
| NSC 760016 | (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one | 0.0280810439814505 | 0.097792676 |